NCT06301087

Brief Summary

The goal of this observational study is to confirm the impact of using this app adapted to be more specific for screening for 5 neurodevelopmental disorders and to evaluate the mothers' support program on the incidence of postpartum depression in of young parents with a minimum of 1 child under 10 years of age at the time of inclusion and using Malo on a regular basis. The main questions it aims to answer are :

  • the median age of possible neurodevelopmental disorders notification of infants
  • the median time of the mothers' postnatal depression notifications after childbirth subsequently to the support and prevention program Participants will agree with use of their data

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55,618

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2024

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

March 1, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 8, 2024

Completed
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

1.8 years

First QC Date

March 1, 2024

Last Update Submit

March 13, 2024

Conditions

Keywords

early detectionneurodevelopmental disorderspostnatal depressionmHealthreal-world studysmartphone

Outcome Measures

Primary Outcomes (1)

  • Time to neurodevelopment desorder diagnostic

    Number of days between birth and notification of possible neurodevelopment desorder notification

    20 months

Secondary Outcomes (4)

  • User's satisfaction

    20 months

  • Relevance of the neurodevelopmental desorder notification

    20 months

  • Rate of mothers'postnal depression

    20 months

  • Time of mothers'postnatal depression

    7 months

Study Arms (1)

users

users of the web-application

Device: Web Application

Interventions

web application for monitoring children's development and postnatal depression of mothers

Also known as: MALO
users

Eligibility Criteria

AgeUp to 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The population will include the first 50,000 users of the application who consent to the use of their data for this assessment young parent withe a minimum of 1 child under 10 years matching the criteria and agreeing to participate

You may qualify if:

  • Youg parent with a minimum of 1 child under 10 years
  • User of the app (downloaded)
  • Having given informed consent (in-app)

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ILC

Le Mans, France

Location

Related Publications (1)

  • Denis F, Le Goff F, Desbois M, Gepner A, Feliciano G, Silber D, Zeitoun JD, Assuied GP. Early Detection of 5 Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression With a Mobile Health App: Observational Cross-Sectional Study. JMIR Public Health Surveill. 2024 Jun 18;10:e58565. doi: 10.2196/58565.

MeSH Terms

Conditions

Depression, PostpartumNeurodevelopmental Disorders

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Study Officials

  • Fabrice DENIS

    Kelindi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2024

First Posted

March 8, 2024

Study Start

May 1, 2022

Primary Completion

February 8, 2024

Study Completion

February 8, 2024

Last Updated

March 15, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations